Peptide record

TPDB41051

BmKn-24 Anticancer standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41051
BmKn-24
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 9-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
FIGAIARLL
Physicochemical Analysis
C47H80N12O10
NDCEQHKMPSTWYV
AIL
973.23
11.05
1
0
7
+1
-2.39
2.011
195.56
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
2
L
0
K
0
M
1
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 2 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
9
C47H80N12O10
973.23
11.05
+1
-2.39
2.011
Free
L
Linear
Free
Antimicrobial
Derivative of Bmkn-2
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50 between 29-97 µg/ml
Anticancer

Target

Tongue Squamous Cell Carcinoma
HSC-4
Tongue

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.